175 related articles for article (PubMed ID: 36824129)
1. A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma.
Song Y; Zhang YY; Yu Q; Chen T; Wei CG; Zhang R; Hu W; Qian XJ; Zhu Z; Zhang XW; Shen JK
Front Oncol; 2023; 13():1123141. PubMed ID: 36824129
[TBL] [Abstract][Full Text] [Related]
2. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.
Chen Y; Qin Y; Wu Y; Wei H; Wei Y; Zhang Z; Duan T; Jiang H; Song B
Front Immunol; 2022; 13():973153. PubMed ID: 36091074
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
[TBL] [Abstract][Full Text] [Related]
4. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
[TBL] [Abstract][Full Text] [Related]
5. A gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
Liang Y; Xu F; Wang Z; Tan C; Zhang N; Wei X; Jiang X; Wu H
Eur J Radiol; 2022 Aug; 153():110356. PubMed ID: 35623312
[TBL] [Abstract][Full Text] [Related]
6. Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping.
Liu Z; Yang S; Chen X; Luo C; Feng J; Chen H; Ouyang F; Zhang R; Li X; Liu W; Guo B; Hu Q
Front Oncol; 2022; 12():954445. PubMed ID: 36313692
[TBL] [Abstract][Full Text] [Related]
7. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
[TBL] [Abstract][Full Text] [Related]
9. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
10. A nomogram model integrating LI-RADS features and radiomics based on contrast-enhanced magnetic resonance imaging for predicting microvascular invasion in hepatocellular carcinoma falling the Milan criteria.
Liu HF; Zhang YZ; Wang Q; Zhu ZH; Xing W
Transl Oncol; 2023 Jan; 27():101597. PubMed ID: 36502701
[TBL] [Abstract][Full Text] [Related]
11. LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.
Song JS; Choi EJ; Hwang SB; Hwang HP; Choi H
Eur Radiol; 2019 Jan; 29(1):401-410. PubMed ID: 29922928
[TBL] [Abstract][Full Text] [Related]
12. A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Zhou H; Sun J; Jiang T; Wu J; Li Q; Zhang C; Zhang Y; Cao J; Sun Y; Jiang Y; Liu Y; Zhou X; Huang P
Front Oncol; 2021; 11():699290. PubMed ID: 34307168
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy.
Hu C; Song Y; Zhang J; Dai L; Tang C; Li M; Liao W; Zhou Y; Xu Y; Zhang YY; Zhou Y
Front Oncol; 2021; 11():649682. PubMed ID: 34094938
[TBL] [Abstract][Full Text] [Related]
14. The Value of LI-RADS and Radiomic Features From MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma within 5 cm.
Feng B; Wang L; Zhu Y; Ma X; Cong R; Cai W; Liu S; Hu J; Wang S; Zhao X
Acad Radiol; 2024 Jan; ():. PubMed ID: 38199902
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study.
Tian Y; Hua H; Peng Q; Zhang Z; Wang X; Han J; Ma W; Chen J
J Magn Reson Imaging; 2022 Nov; 56(5):1459-1472. PubMed ID: 35298849
[TBL] [Abstract][Full Text] [Related]
16. A Nomogram Based on Contrast-Enhanced Ultrasound to Predict the Microvascular Invasion in Hepatocellular Carcinoma.
Bo J; Xiang F; XiaoWei F; LianHua Z; ShiChun L; YuKun L
Ultrasound Med Biol; 2023 Jul; 49(7):1561-1568. PubMed ID: 37003955
[TBL] [Abstract][Full Text] [Related]
17. A nomogram based on PI-RADS v2.1 and clinical indicators for predicting clinically significant prostate cancer in the transition zone.
Wei C; Pan P; Chen T; Zhang Y; Dai G; Tu J; Jiang Z; Zhao W; Shen J
Transl Androl Urol; 2021 Jun; 10(6):2435-2446. PubMed ID: 34295730
[TBL] [Abstract][Full Text] [Related]
18. Can LI-RADS imaging features at gadoxetic acid-enhanced MRI predict aggressive features on pathology of single hepatocellular carcinoma?
Wei H; Jiang H; Liu X; Qin Y; Zheng T; Liu S; Zhang X; Song B
Eur J Radiol; 2020 Nov; 132():109312. PubMed ID: 33022551
[TBL] [Abstract][Full Text] [Related]
19. Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.
Tang Q; Ma C
Oncol Lett; 2018 Aug; 16(2):2725-2731. PubMed ID: 30008946
[TBL] [Abstract][Full Text] [Related]
20. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
Wang S; Yao J; Li K; Yang H; Lu S; He G; Wu W; Cheng W; Jiang T; Ding H; Jing X; Yan Y; Liu F; Yu J; Han Z; Cheng Z; Tan S; Li X; Dou J; Li Y; Qi E; Zhang Y; Liang P; Yu X
Abdom Radiol (NY); 2023 Oct; 48(10):3101-3113. PubMed ID: 37436451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
